%0 Journal Article
%T Relationship between sphingolipids-mediated neuroinflammation and alcohol use disorder.
%A Cui X
%A Li J
%A Wang C
%A Ishaq HM
%A Zhang R
%A Yang F
%J Pharmacol Biochem Behav
%V 235
%N 0
%D 2024 Feb 19
%M 38128765
%F 3.697
%R 10.1016/j.pbb.2023.173695
%X <B>BACKGROUND: </B>Alcohol use disorder is a chronic recurrent encephalopathy, and its pathogenesis has not been fully understood. Among possible explanations, neuroinflammation caused by the disorders of brain central immune signaling has been identified as one possible mechanism of alcohol use disorder. As the basic components of cells and important bioactive molecules, sphingolipids are essential in regulating many cellular activities. Recent studies have shown that sphingolipids-mediated neuroinflammation may be involved in the development of alcohol use disorder.<BR><B>METHODS: </B>PubMed databases were searched for literature on sphingolipids and alcohol use disorder (alcohol abuse, alcohol addiction, alcohol dependence, and alcohol misuse) including evidence of the relationship between sphingolipids-mediated neuroinflammation and alcohol use disorder (formation, withdrawal, treatment).<BR><B>RESULTS: </B>Disorders of sphingolipid metabolism, including the different types of sphingolipids and regulatory enzyme activity, have been found in patients with alcohol use disorder as well as animal models, which in turn cause neuro-inflammation in the central nervous system. Thus, these disorders may also be an important mechanism in the development of alcohol use disorder in patients. In addition, different sphingolipids may have different or even reverse effects on alcohol use disorder.<BR><B>CONCLUSIONS: </B>The sphingolipids-mediated neuroinflammation plays an important role in the development of alcohol use disorder. This review proposes a potential approach to prevent and treat alcohol use disorders by manipulating sphingolipid metabolism.